OpenAlex Citation Counts

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comparative study of smart nanoformulations of diethyldithiocarbamate with Cu4O3 nanoparticles or zinc oxide nanoparticles for efficient eradication of metastatic breast cancer
Marwa M. Abu‐Serie, Eisayeda Zeinab A. Abdelfattah
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15

Showing 15 citing articles:

Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Yumin Wang, Yongming Chen, Junjing Zhang, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101018-101018
Open Access | Times Cited: 95

Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review
Sara Abdolmaleki, Alireza Aliabadi, Samad Khaksar
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 24

Advanced drug delivery platforms target cancer stem cells
MirAhmad Mazloomi, Abolfazl Doustmihan, Sajjad Alimohammadvand, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101036-101036
Open Access | Times Cited: 3

Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: aldehyde dehydrogenase 1A1 suppression and ferroptosis induction
Marwa M. Abu‐Serie, Satoru Osuka, Lamiaa A Heikal, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8

Screening of Cu₄O₃ NPs efficacy and its anticancer potential against cervical cancer
Torki A. Zughaibi, Nasimudeen R. Jabir, Azhar U. Khan, et al.
Cell Biochemistry and Function (2023) Vol. 41, Iss. 8, pp. 1174-1187
Closed Access | Times Cited: 18

Nanoparticle-mediated diagnosis, treatment, and prevention of breast cancer
Lipsa Leena Panigrahi, Pallavi Samal, Sameer Ranjan Sahoo, et al.
Nanoscale Advances (2024) Vol. 6, Iss. 15, pp. 3699-3713
Open Access | Times Cited: 8

Advancements in Breast Cancer Therapy: The Promise of Copper Nanoparticles
C Surya, Ashoka Babu Vechham Lakshminarayana, Sameera Hammigi Ramesh, et al.
Journal of Trace Elements in Medicine and Biology (2024) Vol. 86, pp. 127526-127526
Closed Access | Times Cited: 7

Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids
Marwa M. Abu‐Serie
Nanomedicine (2024) Vol. 19, Iss. 11, pp. 979-994
Closed Access | Times Cited: 6

Superior cuproptotic efficacy of diethyldithiocarbamate-Cu4O3 nanoparticles over diethyldithiocarbamate-Cu2O nanoparticles in metastatic hepatocellular carcinoma
Marwa M. Abu‐Serie, Assem Barakat, Sherif Ramadan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4

Advances in non-apoptotic regulated cell death: implications for malignant tumor treatment
Yizheng Zhang, Shiqi Yi, Mingyuan Luan
Frontiers in Oncology (2025) Vol. 15
Open Access

Ferroptosis- and stemness inhibition-mediated therapeutic potency of ferrous oxide nanoparticles-diethyldithiocarbamate using a co-spheroid 3D model of pancreatic cancer
Marwa M. Abu‐Serie, Ana K. Gutiérrez-García, Macie Enman, et al.
Journal of Gastroenterology (2025)
Open Access

Cancer Stem Cells: Robust Features and Therapeutic Targets
Marwa M. Abu‐Serie, Eman Sarhan
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1

Cuproptosis: a promising new target for breast cancer therapy
Qianqian Jiang, Fei Tong, Yun Xu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1

Assessment of Cytotoxicity activity of novel zinc oxide nanoparticles synthesized through coffee bean and xylitol formulation
Khushali K Shah, Nabeel Ahmed, Dhanraj Ganapathy
Journal of Population Therapeutics and Clinical Pharmacology (2023) Vol. 30, Iss. 12
Open Access | Times Cited: 1

Anticancer potential of Cu4O3 NPs against human ovarian teratocarcinoma: an in-vitro validation
Nasimudeen R. Jabir, Aisha Mahboob, Mohd Suhail, et al.
Chemical Papers (2023) Vol. 78, Iss. 5, pp. 2811-2821
Closed Access

Page 1

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-functional	1 year	The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
CookieLawInfoConsent	1 year	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSID	session	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.

Requested Article:

Showing 15 citing articles:

Your Privacy